Histone demethylase JMJD2C: epigenetic regulators in tumors

被引：11

作者：

Zhang, Chengcheng ^{[1
,2
]}

Wang, Zhongqi ^{[2
]}

Ji, Qing ^{[1
]}

Li, Qi ^{[1
]}

机构：

[1] Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Dept Med Oncol, Shanghai 201203, Peoples R China

[2] Shanghai Univ Tradit Chinese Med, Longhua Hosp, Dept Med Oncol, Shanghai 200032, Peoples R China

来源：

ONCOTARGET | 2017年 / 8卷 / 53期

基金：

中国国家自然科学基金; 上海市自然科学基金;

关键词：

histone demethylase; JMJD2C; epigenetic regulation; tumor; ACUTE MYELOID-LEUKEMIA; EMBRYONIC STEM-CELL; HUMAN BREAST-CANCER; ANDROGEN RECEPTOR; LYSINE DEMETHYLASE; PROSTATE-CANCER; DNA-DAMAGE; CHROMOSOME SEGREGATION; GENETIC ALTERATIONS; GAMMA-H2AX ASSAY;

D O I：

10.18632/oncotarget.19176

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Histone methylation is one of the major epigenetic modifications, and various histone methylases and demethylases participate in the epigenetic regulating. JMJD2C has been recently identified as one of the histone lysine demethylases. As one member of the Jumonji-C histone demethylase family, JMJD2C has the ability to demethylate tri- or di-methylated histone 3 and 2 in either K9 (lysine residue 9) or K36 (lysine residue 36) sites by an oxidative reaction, thereby affecting heterochromatin formation, genomic imprinting, X-chromosome inactivation, and transcriptional regulation of genes. JMJD2C was firstly found to involve in embryonic development and stem cell regulation. Afterwards, aberrant status of JMJD2C histone methylation was observed during the formation and development of various tumors, and it has been reported to play crucial roles in the progression of breast cancer, prostate carcinomas, osteosarcoma, blood neoplasms and so on, indicating that JMJD2C represents a promising anti-cancer target. In this review, we will focus on the research progress and prospect of JMJD2C in tumors, and provide abundant evidence for the functional application and therapeutic potential of targeting JMJD2C in tumors.

引用

页码：91723 / 91733

页数：11

共 89 条

[41]

Labbé RM, 2014, AM J TRANSL RES, V6, P1

[42] Hypoxia enhances the expression of prostate-specific antigen by modifying the quantity and catalytic activity of Jumonji C domain-containing histone demethylases [J].

Lee, Ho-Youl ;

Yang, Eun Gyeong ;

Park, Hyunsung .

CARCINOGENESIS, 2013, 34 (12) :2706-2715

[43] Serine is a new target residue for endogenous ADP-ribosylation on histones [J].

Leidecker, Orsolya ;

Bonfiglio, Juan Jose ;

Colby, Thomas ;

Zhang, Qi ;

Atanassov, Ilian ;

Zaja, Roko ;

Palazzo, Luca ;

Stockum, Anna ;

Ahel, Ivan ;

Matic, Ivan .

NATURE CHEMICAL BIOLOGY, 2016, 12 (12) :998-+

[44] Jumonji domain containing 2C promotes cell migration and invasion through modulating CUL4A expression in lung cancer [J].

Li, Na ;

Jiang, Dazhi .

BIOMEDICINE & PHARMACOTHERAPY, 2017, 89 :305-315

[45] Histone demethylase JMJD2B and JMJD2C induce fibroblast growth factor 2: mediated tumorigenesis of osteosarcoma [J].

Li, Xiaojiang ;

Dong, Shanshan .

MEDICAL ONCOLOGY, 2015, 32 (03)

[46] Genomic amplification and oncogenic properties of the GASC1 histone demethylase gene in breast cancer [J].

Liu, G. ;

Bollig-Fischer, A. ;

Kreike, B. ;

van de Vijver, M. J. ;

Abrams, J. ;

Ethier, S. P. ;

Yang, Z-Q .

ONCOGENE, 2009, 28 (50) :4491-4500

[47] Jmjd1a and Jmjd2c histone H3 Lys 9 demethylases regulate self-renewal in embryonic stem cells [J].

Loh, Yuin-Han ;

Zhang, Weiwei ;

Chen, Xi ;

George, Joshy ;

Ng, Huck-Hui .

GENES & DEVELOPMENT, 2007, 21 (20) :2545-2557

[48] Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progression [J].

Luo, Weibo ;

Chang, Ryan ;

Zhong, Jun ;

Pandey, Akhilesh ;

Semenza, Gregg L. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (49) :E3367-E3376

[49] Glucocorticoid receptor regulates accurate chromosome segregation and is associated with malignancy [J].

Matthews, Laura C. ;

Berry, Andrew A. ;

Morgan, David J. ;

Poolman, Toryn M. ;

Bauer, Kerstin ;

Kramer, Frederike ;

Spiller, David G. ;

Richardson, Rachel V. ;

Chapman, Karen E. ;

Farrow, Stuart N. ;

Norman, Michael R. ;

Williamson, Andrew J. K. ;

Whetton, Anthony D. ;

Taylor, Stephen S. ;

Tuckermann, Jan P. ;

White, Michael R. H. ;

Ray, David W. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (17) :5479-5484

[50] Histone H3 lysine 4 acetylation and methylation dynamics define breast cancer subtypes [J].

Messier, Terri L. ;

Gordon, Jonathan A. R. ;

Boyd, Joseph R. ;

Tye, Coralee E. ;

Browne, Gillian ;

Stein, Janet L. ;

Lian, Jane B. ;

Stein, Gary S. .

ONCOTARGET, 2016, 7 (05) :5094-5109

← 1 2 3 4 5 6 7 8 9 →